Who qualifies for Saxenda?
Saxenda · liraglutide · by Novo Nordisk
Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
FDA indication: adults BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity. Adolescents 12+ with body weight >60 kg also approved. Insurance coverage often requires step therapy from older anti-obesity drugs.
More on Saxenda
- How much does Saxenda cost?
- Saxenda side effects
- Saxenda dosing and titration schedule
- How does Saxenda work?
- Saxenda drug interactions
- Saxenda and pregnancy: safety, planning, breastfeeding
- Saxenda and alcohol: what to know
- Saxenda missed dose: what to do
- Saxenda savings: coupons, manufacturer programs, lower-cost options
- ← Full Saxenda overview
Frequently asked
Am I eligible for Saxenda?+
FDA indication: adults BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity. Adolescents 12+ with body weight >60 kg also approved. Insurance coverage often requires step therapy from older anti-obesity drugs.
Who should not take Saxenda?+
Anyone with the documented contraindications listed above. Always disclose full medical history, current medications, and family cancer history to the prescribing clinician.